Quick Answer
ASSEMBLY BIOSCIENCES, INC. reported R&D Expense of $64.81 million for fiscal year 2025.
ASSEMBLY BIOSCIENCES, INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $64.81M | +15.9% |
| 2024 | $55.93M | +14.4% |
| 2023 | $48.90M | -30.1% |
| 2022 | $69.98M | +2.1% |
| 2021 | $68.52M | -35.9% |
| 2020 | $106.82M | +24.6% |
| 2019 | $85.76M | +17.9% |
| 2018 | $72.74M | +64.5% |
| 2017 | $44.23M | +33.6% |
| 2016 | $33.09M | +80.3% |
| 2015 | $18.36M | +71.3% |
| 2014 | $10.72M | +134.2% |
| 2013 | $4.58M | -76.6% |
| 2012 | $19.51M | -22.8% |
| 2011 | $25.28M | +1265.9% |
| 2010 | $1.85M | -37.1% |
| 2009 | $2.94M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $16.59M | +22.7% | +2.9% |
| June 30, 2025 | $16.12M | -0.8% | +8.6% |
| March 31, 2025 | $14.85M | +25.0% | +9.9% |
| September 30, 2024 | $13.52M | +24.9% | -16.9% |
| June 30, 2024 | $16.26M | +29.8% | +36.9% |
| March 31, 2024 | $11.88M | -18.3% | +9.7% |
| September 30, 2023 | $10.82M | -40.3% | -13.6% |
| June 30, 2023 | $12.52M | -29.6% | -13.9% |
- ASSEMBLY BIOSCIENCES, INC. showed an increase of +15.9% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2025 period, ASSEMBLY BIOSCIENCES, INC.’s r&d expense has grown by 2102.3% (from $2.94 million to $64.81 million).
- The most recent figure is from ASSEMBLY BIOSCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: